Reimbursement, Redistribution of COVID-19 Therapeutics and More

Date: 
Thursday, January 6, 2022

The January 5, 2022 COVID-19 Therapeutics Brief  includes detailed information on the following highlights.

  • Using Therapeutics to Prevent and Treat COVID-19
  • Therapeutic Resources
  • Redistribution Requests for Therapeutics
  • Informational Letter from Iowa Department of Human Services, Iowa Medicaid Enterprise Regarding Monoclonal Antibody Reimbursement
  • Weekly Allocations Cadence for Monoclonal Antibodies, Pre-Exposure Prophylaxis Treatment and Antivirals

Healthcare provider questions regarding COVID-19 therapeutics can be directed to the C19 Therapeutics Call Center at (515) 281-7317 or emailed to  C19Therapeutics@idph.iowa.gov.

Printed from the Iowa Board of Pharmacy website on May 24, 2022 at 7:27am.